DROPERIDOL
Droperidol Adverse Events Reported to the FDA Over Time
How are Droperidol adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Droperidol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Droperidol is flagged as the suspect drug causing the adverse event.
Most Common Droperidol Adverse Events Reported to the FDA
What are the most common Droperidol adverse events reported to the FDA?
| Renal Failure Acute | 53 (5.81%) |
| Oliguria | 37 (4.05%) |
| Haematuria | 33 (3.61%) |
| Lymphopenia | 27 (2.96%) |
| Nausea | 18 (1.97%) |
| Tachycardia | 16 (1.75%) |
| Blood Creatinine Increased | 15 (1.64%) |
| Product Quality Issue | 14 (1.53%) |
| Dyspnoea | 13 (1.42%) |
| Hyperhidrosis | 13 (1.42%) |
| Restless Legs Syndrome | 12 (1.31%) |
 Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Droperidol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Droperidol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Adverse Event Categories for Droperidol
What are the most common Droperidol adverse events reported to the FDA?
| Renal Disorders | 96 (10.51%) |
| Cardiac Arrhythmias | 68 (7.45%) |
| Respiratory | 48 (5.26%) |
| Cardiac And Vascular Investigations | 41 (4.49%) |
| Movement Disorders | 41 (4.49%) |
| Neurological | 40 (4.38%) |
| Urinary Tract Signs | 36 (3.94%) |
| Gastrointestinal Signs | 32 (3.5%) |
| White Blood Cell | 29 (3.18%) |
| Procedural And Device Related Injur... | 23 (2.52%) |
| Changes In Physical Activity | 20 (2.19%) |
| Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Droperidol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Droperidol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Common Uses of Droperidol According to Those Reporting Adverse Events
Why are people taking Droperidol, according to those reporting adverse events to the FDA?
| Drug Use For Unknown Indication | 31 |
| Nausea | 30 |
| Anaesthesia | 20 |
| Product Used For Unknown Indication | 19 |
| General Anaesthesia | 15 |
| Pain | 13 |
| Show More |
Drug Labels
| Label | Labeler | Effective |
|---|---|---|
| Droperidol | Hospira, Inc. | 12-AUG-11 |
| Droperidol | American Regent, Inc. | 08-OCT-11 |
| Inapsine | Akorn, Inc. | 22-DEC-11 |
| Droperidol | Cardinal Health | 09-MAY-12 |
| Droperidol | General Injectables & Vaccines, Inc | 18-OCT-12 |
Droperidol Case Reports
What Droperidol safety concerns are being reported by doctors and researchers in the medical literature?
About Results
This report contains aggregated drug side effects and adverse events for Droperidol. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Comments
Share your experience with Droperidol.